LABCORP HOLDINGS INC.

Labcorp® Holdings Inc. is a global provider of innovative and comprehensive laboratory services. The company offers vital information to doctors, hospitals, pharmaceutical companies, researchers, and patients to aid decision-making. Labcorp provides insights and accelerates innovations to improve health through its diagnostics and drug development laboratory capabilities. In 2025, the company's nearly 71,000 employees served clients in approximately 100 countries and performed over 750 million tests for patients globally. Additionally, Labcorp supported more than 85% of the new drugs and therapeutic products approved by the FDA in 2025. The company leverages its strengths in science, technology, innovation, and global scale to advance healthcare. Labcorp's enterprise strategy involves providing vital information and services through leadership in science, technology, and innovation. The company is expanding its role in the healthcare market by strengthening its capabilities, pursuing strategic opportunities, and differentiating its offerings. Labcorp is focused on two near-term strategic growth opportunities across both Dx and BLS: being a partner of choice for health systems and local and regional laboratories, and leading in the development, licensing, and scaling of specialty testing. In 2025, the company signed or completed 13 collaboration transactions with health systems and local and regional laboratories. These partnerships are sought based on financial criteria, including being accretive in the first year, returning the cost of capital within three years, and providing a clear path to margin improvement.